Insights provides context and perspective about key pharmacy trends and issues

Specialty
The First Biosimilar to Humira Is Here More
Briefing
Female caregiver and elderly patient discussing medical information on a couch
Specialty
Research published by Coram shows that helping patients transition to at-home or ambulatory center infusion treatments can be beneficial to both patients and payors. More
Briefing
Icon of an infusion bag, overlaying a rising line graph
Specialty
Multiple Sclerosis is a $19 billion market worldwide, and the third most expensive specialty drug spend category. Recently approved Ocrevus is likely to add to cost of treatment and needs... More
Briefing
Specialty
A Virtual Approach to Keep Specialty Costs Down More
Briefing
A smiling pharmacist talks on the phone
Specialty
Monitoring efficacy and outcomes of high cost specialty medications can help lower costs for payors More
Briefing
Specialty
CVS Health leader discusses the value of being connected in care to patients and providers More
Briefing
Specialty
PAH is a rare, life-threatening disease, which is incurable. It is difficult to manage and to help ensure the longest survival and best possible quality of life, members need comprehensive... More
Briefing
Specialty
The Top Challenges Facing Gene Therapy Today More
Briefing
Specialty
Multiple Specialty Vendors Mean More Headaches More
Commentary
Specialty
Integrated specialty management solutions are crucial to balance cost and access More
Briefing